AbbVie (ABBV) Plans Pipeline Update at R&D Day Event; Includes IMBRUVICA, ABT-484 Data

June 3, 2016 8:12 AM

At an R&D Day meeting today for the investment community, AbbVie (NYSE: ABBV) will present an overview of its innovative ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found